127 related articles for article (PubMed ID: 9298839)
1. Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas.
Kunikane H; Zalupski MM; Ramachandran C; KuKuruga MA; Lucas D; Ryan JR; Krishan A
Cytometry; 1997 Aug; 30(4):197-203. PubMed ID: 9298839
[TBL] [Abstract][Full Text] [Related]
2. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
[TBL] [Abstract][Full Text] [Related]
3. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
[TBL] [Abstract][Full Text] [Related]
4. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
[TBL] [Abstract][Full Text] [Related]
5. Anthracycline drugs and MDR expression in human leukemia.
Pogliani EM; Belotti D; Rivolta GF; Maffè PF; Corneo G
Cytotechnology; 1996; 19(3):229-35. PubMed ID: 8862011
[TBL] [Abstract][Full Text] [Related]
6. Expression of MDR1/P glycoprotein in human sarcomas.
Vergier B; Cany L; Bonnet F; Robert J; de Mascarel A; Coindre JM
Br J Cancer; 1993 Dec; 68(6):1221-6. PubMed ID: 7903154
[TBL] [Abstract][Full Text] [Related]
7. Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.
Kim Y; Kobayashi E; Kubota D; Suehara Y; Mukaihara K; Akaike K; Ito A; Kaneko K; Chuman H; Kawai A; Kitano S
Oncotarget; 2016 Oct; 7(43):70832-70844. PubMed ID: 27683125
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression in soft-tissue sarcomas.
Nakanishi H; Myoui A; Ochi T; Aozasa K
J Cancer Res Clin Oncol; 1997; 123(6):352-6. PubMed ID: 9222302
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
10. Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.
Ferrao P; Sincock P; Cole S; Ashman L
Leuk Res; 2001 May; 25(5):395-405. PubMed ID: 11301107
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study.
Lizard G; Roignot P; Maynadie M; Lizard-Nacol S; Poupon MF; Bordes M
Cancer Detect Prev; 1995; 19(6):527-34. PubMed ID: 8925522
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line.
Ramachandran C; Kunikane H; You W; Krishan A
Biochem Pharmacol; 1998 Sep; 56(6):709-18. PubMed ID: 9751075
[TBL] [Abstract][Full Text] [Related]
13. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
Yang JY; Luo HY; Lin QY; Liu ZM; Yan LN; Lin P; Zhang J; Lei S
World J Gastroenterol; 2002 Aug; 8(4):644-9. PubMed ID: 12174371
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric double labeling technique for screening of multidrug resistance.
Gheuens EE; van Bockstaele DR; van der Keur M; Tanke HJ; van Oosterom AT; De Bruijn EA
Cytometry; 1991; 12(7):636-44. PubMed ID: 1685985
[TBL] [Abstract][Full Text] [Related]
15. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
16. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
18. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]